Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Molly Klein"'
Publikováno v:
Case Reports in Pathology, Vol 2019 (2019)
Tumor of the follicular infundibulum or infundibuloma is a relatively rare benign adnexal tumor usually solitary and located in the head, neck, and trunk. Here we present a 70-year-old woman with a tender vulvar lesion. Histopathologic exam shows a w
Externí odkaz:
https://doaj.org/article/7ca95c985aaa43aeb285280c7201a3ca
Publikováno v:
Case Reports in Urology, Vol 2016 (2016)
Introduction. Angiomyolipomas are the most common benign tumor of the kidney, associated with Tuberous Sclerosis in 20% of cases and arising sporadically in 80% of cases. Renal angiomyolipomas are neoplasms of mesenchymal origin with varying proporti
Externí odkaz:
https://doaj.org/article/77a8f9bd1e7d417db8976f7071badb33
Autor:
Sonal Shad, William Fraser Symmans, Debu Tripathy, Lamorna Brown-Swigart, LJ Esserman, Jane Perlmutter, V. Valero, Rebekah Gould, Gregor Krings, Judy C. Boughey, Jodi M. Carter, M. van der Noordaa, Gillian L. Hirst, L.J. van 't Veer, Christina Yau, Douglas Yee, Lajos Pusztai, Tufia C. Haddad, Kathy S. Albain, Molly Klein, Lili Du, MC Liu, Rita Nanda, Claudine Isaacs, Richard Schwab, Amy Jo Chien, Donald A. Berry, Rachel M. Layman, AM DeMichele, Isabelle Bedrosian, Sara J. Venters, Nola M. Hylton
Publikováno v:
Annals of Oncology. 32:642-651
BACKGROUND We proposed that a test for sensitivity to the adjuvant endocrine therapy component of treatment for patients with stage II-III breast cancer (SET2,3) should measure transcription related to estrogen and progesterone receptors (SETER/PR in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::082ef2b88b706887b4cdf6ebbaef357d
https://doi.org/10.1016/j.annonc.2021.02.011
https://doi.org/10.1016/j.annonc.2021.02.011
Autor:
Molly Klein, Alexander D. Borowsky, Gregor Krings, Ronald Balassanian, I Tolgay Ocal, Sunati Sahoo, Denise M. Wolf, Kimberley Cole, Shuko Harada, Amy L. Delson, Laura van 't Veer, Kamaljeet Singh, Kimmie Rabe, W. Fraser Symmans, Sara J. Venters, Sonal Shad, Yunn-Yi Chen, Laura J. Esserman, Malini Harigopal, Lamorna Brown-Swigart, Jodi M. Carter, Laila Khazai
Publikováno v:
Cancer Research. 81:PS4-09
Background: I-SPY 2 is a neoadjuvant platform trial open to patients with locally advanced, molecular high-risk breast cancer. In a concerted pursuit of mid-therapy response biomarkers, we evaluated inter-regimen biopsies, to identify patients who ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6186374efd0cdd3401a62dd0031da0e8
https://doi.org/10.1158/1538-7445.sabcs20-ps4-09
https://doi.org/10.1158/1538-7445.sabcs20-ps4-09
Autor:
Sonal Shad, Nola M. Hylton, Alexander D. Borowsky, David C. Newitt, Shuko Harada, Sara J. Venters, Ronald Balassanian, Molly Klein, I Tolgay Ocal, Sunati Sahoo, Wen Li, Kamaljeet Singh, Kimmie Rabe, Amy L. Delson, Laura van 't Veer, Christina Yau, Gregor Krings, W. Fraser Symmans, Natsuko Onishi, Kimberley Cole, Jessica Gibbs, Jodi M. Carter, Laila Khazai, Malini Harigopal, Barbara LeStage, Yunn-Yi Chen, Denise M. Wolf, Sandra Finestone, Laura J. Esserman, Lamorna Brown-Swigart
Publikováno v:
Cancer Research. 81:PS4-10
Background: The I-SPY 2 TRIAL, open to patients with locally advanced, molecular high-risk breast cancer, aims to bring each patient to pathologic complete response (pCR) with a minimum of toxicity. Here we test the hypothesis that imaging (MR volume
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5e7aada35080cbe3930b6b957ea2497
https://doi.org/10.1158/1538-7445.sabcs20-ps4-10
https://doi.org/10.1158/1538-7445.sabcs20-ps4-10
Autor:
Shari Damast, Molly Klein, Omar Najjar, Joan Tymon-Rosario, Britt K. Erickson, Alessandro D. Santin, Adriana Blakaj, Rebecca L. Stone, Michelle M Dolan, J. Stuart Ferriss, Ashley Cimino-Mathews, Maryam Shahi, Amanda N. Fader, Natalia Buza, Mahmoud A. Khalifa
Publikováno v:
Gynecologic Oncology. 159:17-22
Background Human epidermal growth factor receptor 2 (HER2) has emerged as an important prognostic and therapeutic target in advanced stage and recurrent uterine serous carcinoma (USC). The significance of tumoral HER2 expression in early-stage diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52adc17138b7e93ef0a061e7c9c33a3f
https://doi.org/10.1016/j.ygyno.2020.07.016
https://doi.org/10.1016/j.ygyno.2020.07.016
Autor:
Susanna R Clark, Maryna Tarbunova, Tanya Jorden, Molly Klein, Mahmoud A. Khalifa, Joseph W Rudolf
Publikováno v:
American Journal of Clinical Pathology
Objectives We sought to make pathologists’ intraoperative consultation (IOC) results immediately available to the surgical team, other clinicians, and laboratory medicine colleagues to improve communication and decrease postanalytic errors. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c3d859d71de6f67446d2fc983a9475e
http://europepmc.org/articles/PMC7403756
http://europepmc.org/articles/PMC7403756
Autor:
Cheryl Ewing, Gretchen M. Ahrendt, Anne M. Wallace, Gregor Krings, Helen Krontiras, Christina Yau, Kimberly Cole, Sunati Sahoo, Julie E. Lang, Dina Kokh, Brigid K. Killelea, Akiko Chiba, Tod Tuttle, W. Fraser Symmans, Molly Klein, Arpana Naik, Yunn-Yi Chen, Marie Osdoit, Constantine Godellas, Roshni Rao, Nora Jaskowiak, Laura J. Esserman, Bev Parker, Julia Tchou, Rita A. Mukhtar, Ronald Balassanian, Smita Asare, Jodi M. Carter, M. Catherine Lee, Eleni A. Tousimis, Laila Khazai, Shannon Tierney, Judy C. Boughey, Rachael Lancaster
Publikováno v:
Cancer Research. 80:P3-08
Background: Patients who achieve a pathological complete response (pCR- defined as no invasive cancer) after neoadjuvant chemotherapy (NAC) for breast cancer (BC) have improved outcomes, but there is still controversy about the significance of residu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66b516c77eeb79849992c7472cd2bfb6
https://doi.org/10.1158/1538-7445.sabcs19-p3-08-16
https://doi.org/10.1158/1538-7445.sabcs19-p3-08-16
Autor:
Michelle E. Melisko, Kirsten K. Edmiston, HS Han, W. Fraser Symmans, Gregor Krings, Molly Klein, Rita Nanda, Claudine Isaacs, Rebecca K. Viscusi, Sunati Sahoo, David M. Euhus, Jeffrey B. Matthews, Angela DeMichele, Erica Stringer-Reasor, Qamar J. Khan, Laura J. van't Veer, Tara Sanft, Christina Yau, Donald A. Berry, Richard Schwab, Janice Lu, Jane Perlmutter, A. Jo Chien, Donald W. Northfelt, Anne M. Wallace, Zaha Mitri, Jane L. Meisel, Julie E. Lang, Jodi M. Carter, Lajos Pusztai, Hope S. Rugo, Rachel L. Yung, Erin D. Ellis, Anthony D. Elias, Laila Khazai, Kathy S. Albain, Yunn-Yi Chen, Nola M. Hylton, Amy S. Clark, Laura J. Esserman, Christos Hatzis, Judy C. Boughey, Douglas Yee, Kimberly Cole, Dina Kokh
Publikováno v:
Cancer Research. 80:P2-20
Background: Achieving a pathologic complete response (pCR) has been shown on the patient level to predict excellent long-term event-free survival outcomes. Residual cancer burden (RCB) quantifies the extent of residual disease for patients who did no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53a3c3bbf1436ab8c293f4edb7054a76
https://doi.org/10.1158/1538-7445.sabcs19-p2-20-02
https://doi.org/10.1158/1538-7445.sabcs19-p2-20-02
Autor:
Jane Wei, Jodi M. Carter, Laila Khazai, Laura J. van't Veer, Molly Klein, Gregor Krings, Dina Kokh, Kimberly Cole, Yunn-Yi Chen, Lamorna Brown-Swigart, Ronald Balassanian, Sara J. Venters, Laura J. Esserman, Bev Parker, Amy L. Delson, Christina Yau, Sunati Sahoo, W. Fraser Symmans, Denise M. Wolf
Publikováno v:
Cancer Research. 80:P6-10
Background: The I-SPY 2 TRIAL enrolls women with locally advanced, molecular high-risk breast cancer. An integrated Residual Cancer Burden (iRCB), based on MRI volume change through treatment, is used to predict pathologic complete response (pCR) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51b39a13bb371f3d4aaf7b9450c9fdd1
https://doi.org/10.1158/1538-7445.sabcs19-p6-10-02
https://doi.org/10.1158/1538-7445.sabcs19-p6-10-02